Archives

Webinar: Bead-Based Assays Detect Antibiotics in Livestock

October 3rd, 2018 / Christine Valle

Scientists use multiplexing technology to look for dozens of antibiotic signatures At the RIKILT institute at Wageningen University & Research in The Netherlands, the mission is “safe and reliable food for everyone” — which is why scientists are diligently developing new tests to assess the health of livestock. In this video presentation, researcher Jeroen Peters

Continue reading »

Multiplex Test Reveals Molecular Subtypes of Breast Cancer

September 18th, 2018 / Hilary Graham

Video protocol shows how to get robust results even from FFPE and other challenging samples Sometimes there’s nothing better than watching someone else perform a protocol to understand how it’s done. That’s the concept behind JoVE, or the Journal of Visualized Experiments, which is kind of like YouTube for scientific techniques. In a new video

Continue reading »

Webinar: Kidney Function Study Suggests Biomarkers Associated with IgA Nephropathy

September 5th, 2018 / Hilary Graham

xMAP® multiplex assays were used to interrogate samples In work powered in part by Luminex’s xMAP® Technology, scientists have uncovered promising biomarkers that may signal the loss of renal function in people with IgA nephropathy, the most common form of glomerulonephritis. In this 10-minute video presentation, David Wimbury from the University of Leicester shares experimental

Continue reading »

Webinar: Multiplex Assay Offers Improved Freshwater Toxicity Testing

August 22nd, 2018 / Hilary Graham

Ecotoxicity program turns to xMAP® Technology for multi-biomarker detection A vital tool for assessing the toxicity of freshwater ecosystems is the tiny Gammarus fossarum, an amphipod crustacean often used as model organisms and bioindicators for ecotoxicology programs. In a 30-minute webinar presentation, Associate Professor Stéphane Azoulay, from the University of Côte d’Azur, described the design

Continue reading »

Webinar: xMAP® Technology Drives Development of Prostate Cancer Detection Assay

August 8th, 2018 / Hilary Graham

Better test accuracy reduces the need for invasive biopsy procedures For a startup company striving to deliver diagnostics that improve health care for patients who may have prostate cancer, Luminex’s xMAP® Technology is a critical tool in the assay development process. According to a webinar presentation from Ramy Huber, a research associate at ProteoMediX, the assay

Continue reading »

Webinar Wednesday: For Tracking Anti-Apoptosis Proteins, Scientists Turn to Multiplexing

July 25th, 2018 / Hilary Graham

AbbVie team uses Luminex-based immunoassay for drug discovery applications According to Dr. Lloyd Lam, a senior scientist at AbbVie, measuring the expression of anti-apoptotic proteins such as BCL-2 is an easier and more cost-effective task when done with a multiplex immunoassay. Lam spoke in a Nature webinar entitled “Multiplex assays of the anti-apoptotic BCL-2 family,”

Continue reading »

How to Multiplex Analysis of Autoimmune Biomarkers

July 11th, 2018 / Hilary Graham

At Protagen, scientists enlist xMAP® Technology to characterize autoantibodies Multiplex analysis of autoantibodies is an effective way to understand autoimmune disease, discover important biomarkers, and stratify patients into subgroups, according to Hans-Dieter Zucht, Head of Technology at Protagen. The company uses a biomarker discovery platform for autoimmune disease and immuno-oncology applications. In a presentation about autoantibody

Continue reading »

Webinar Wednesday: Immunoassay Multiplexing Master Class

June 20th, 2018 / Hilary Graham

From assay development to workflow protocols, how to run a multiplex immunoassay If you could run in 3 hours an immunoassay workflow that would normally take more than 60 hours, that wouldn’t be a tough decision, would it? A step-by-step tutorial webinar from Brett Houser at Bio-Rad shows you exactly how to make that transition.

Continue reading »

xMAP® Assays Reveal More About Immune Response than Traditional Vaccine ELISAs

May 30th, 2018 / Hilary Graham

Serotype-specific assays pinpoint threshold values missed by standard tests If you use ELISAs to test immunological responses, Siân Faustini from the University of Birmingham has this advice: “Serotype-specific assays are the way to go.” In her 20-minute webinar presentation from xMAP® Connect 2017, “Exploring immunological assays to assess responses to pneumococcal polysaccharide and conjugate vaccines

Continue reading »

Webinar Wednesday: Overcome Biomarker Multiplexing Challenges in Drug Development

April 18th, 2018 / Hilary Graham

Paul Rhyne from BDS Shares Recommended Multiplexing Techniques Paul Rhyne, PhD, Chief Scientific Officer at Biologic Development Services (BDS), shares insights from a review article co-authored with 11 colleagues from pharmaceutical companies, clinical research organizations (CRO), and government agencies over two years titled: Recommendations for Use and Fit-for-Purpose Validation of Biomarker Multiplex Ligand Binding Assays in

Continue reading »